Study: 1 Pill Cuts HIV Risk 70%

At least for gay men who remember to take it
By Kevin Spak,  Newser Staff
Posted Nov 23, 2010 9:50 AM CST
Study: 1 Pill Cuts HIV Risk 70%
This May 26, 2006 file photo, shows a close up of Gilead Sciences Inc.'s Truvada pill in a lab in a Foster City, Calif.   (AP Photo/Paul Sakuma, File)

Researchers have hit on what some are calling the first major breakthrough in AIDS prevention medication. By combining two HIV drugs, they’ve created a pill that reduces the risk of contracting the virus by an average of 44%, and by more than 70% if subjects were conscientious about taking it, the LA Times reports. The study was conducted on a group of 2,500 high-risk gay men, but scientists see no reason it wouldn’t work in other populations as well.

The study comes on the heels of an African study showing that a microbicidal gel could help protect women from the disease, and a little over a year after a promising vaccine trial. “To see all these prevention strategies come together, we can begin to see an end to the epidemic,” said a member of the Presidential Advisory Council on HIV/AIDS. Indeed, a UNAID report yesterday revealed that more than 1.2 million people began taking anti-HIV therapies last year, a 30% increase. (Read more HIV/AIDS stories.)

We use cookies. By Clicking "OK" or any content on this site, you agree to allow cookies to be placed. Read more in our privacy policy.
Get the news faster.
Tap to install our app.
Install the Newser News app
in two easy steps:
1. Tap in your navigation bar.
2. Tap to Add to Home Screen.